An H3-clade neutralizing antibody screened from an H7N9 patient that binds group 2 influenza A hemagglutinins

a group 2 HA binding antibody AF4H1K1 Fab heavy chain

a group 2 HA binding antibody AF4H1K1 Fab light chain

QVQLVESGGGVVQPGTSLRLSCEASGFTSSAYAMHWVRQAPGKGLEWVAVITFDGGYQYYADSVKGRFTISRDISRNTLH
LHMNSLRAEDTAVYYCARDPLTKLLPFDWVSGGYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDY
FPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDK

SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAM
DEADYYCQAWDSSTVVFGTGTKVTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVE
TTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECSHHHHHH

influenza virus, H3-clade, neutralizing antibody, H7N9-infected patient, next generation sequencing, IMMUNE SYSTEM